• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较研究肉毒杆菌注射治疗甲状腺相关眼病进展期伴上睑退缩患者的疗效(6 个月随访)。

Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage.

机构信息

Oculoplastic and Orbital Diseases Services, Hospital das Clínicas of the University of São Paulo Medical School, São Paulo, Brazil.

出版信息

Eye (Lond). 2009 Apr;23(4):767-73. doi: 10.1038/eye.2008.165. Epub 2008 Jun 6.

DOI:10.1038/eye.2008.165
PMID:18535592
Abstract

AIM

To compare morphometric data of the eyelid fissure and the levator muscle function (LF) before and up to 6 months after transcutaneous injection with five units of Botox in patients with upper lid retraction (ULR) from congestive or fibrotic thyroid eye disease (TED).

METHODS

Twenty-four patients with ULR from TED were submitted to transcutaneous injection of 5 units (0.1 ml) of Botox in one eye only. Patients were divided into two groups: 12 with congestive-stage TED (CG), and 12 with fibrotic-stage TED (FG). Bilateral lid fissure measurements using digital imaging and computer-aided analysis were taken at baseline and at regular intervals 2 weeks, 1 month, 3 months and 6 months after unilateral Botox injection. Mean values taken at different follow-up points were compared for the two groups.

RESULTS

Most patients experienced marked improvement in ULR, with a mean reduction of 3.81 mm in FG and 3.05 mm in CG. The upper eyelid margin reflex distance, fissure height and total area of exposed interpalpebral fissure were significantly smaller during 1 month in CG and during 3 months in FG. Reduction in LF and in the difference between lateral and medial lid fissure measurements was observed in both groups. The treatment lasted significantly longer in FG than in CG.

CONCLUSIONS

A single 5-unit Botox injection improved ULR, reduced LF and produced an adequate lid contour in patients with congestive or fibrotic TED. The effect lasts longer in patients with fibrotic orbitopathy than in patients with congestive orbitopathy.

摘要

目的

比较 5 单位肉毒毒素经皮注射治疗甲状腺相关眼病(thyroid eye disease,TED)所致上睑退缩(upper lid retraction,ULR)患者上睑提肌功能(levator muscle function,LF)和睑裂形态的变化。

方法

24 例 TED 患者的单眼接受 5 单位(0.1ml)肉毒毒素经皮注射,根据病变处于活动期(congestive stage,CG)还是纤维增殖期(fibrotic stage,FG)分为两组,CG 组 12 例,FG 组 12 例。采用数字成像和计算机辅助分析技术测量双侧睑裂,分别在基线及注射后 2 周、1 个月、3 个月和 6 个月时随访。比较两组各随访时间点的平均值。

结果

大部分患者 ULR 显著改善,FG 组和 CG 组的上睑缘提升高度分别平均减少 3.81mm 和 3.05mm。CG 组在 1 个月和 FG 组在 3 个月时,上睑缘位置、睑裂高度和暴露的睑裂总面积均显著减小。两组 LF 均减小,外侧和内侧睑裂高度差值减小。FG 组治疗效果持续时间明显长于 CG 组。

结论

单次 5 单位肉毒毒素注射可改善 ULR,减少 LF,使 CG 和 FG 患者的上睑外观得到改善。FG 组的治疗效果持续时间长于 CG 组。

相似文献

1
Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage.比较研究肉毒杆菌注射治疗甲状腺相关眼病进展期伴上睑退缩患者的疗效(6 个月随访)。
Eye (Lond). 2009 Apr;23(4):767-73. doi: 10.1038/eye.2008.165. Epub 2008 Jun 6.
2
Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease.经皮注射Dysport治疗甲状腺眼病相关的上睑退缩
Orbit. 2010 Apr;29(2):114-8. doi: 10.3109/01676830903324268.
3
A review of surgical techniques to correct upper eyelid retraction associated with thyroid eye disease.甲状腺相关眼病伴上睑退缩的手术治疗方法综述。
Curr Opin Ophthalmol. 2011 Sep;22(5):391-3. doi: 10.1097/ICU.0b013e3283499433.
4
A single transcutaneous injection with Botox for dysthyroid lid retraction.肉毒杆菌毒素经皮单次注射治疗甲状腺功能异常性眼睑退缩。
Eye (Lond). 2004 May;18(5):466-9. doi: 10.1038/sj.eye.6700690.
5
Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease.结膜下注射曲安奈德治疗甲状腺眼病相关的上睑退缩。
J Craniofac Surg. 2012 Nov;23(6):1755-8. doi: 10.1097/SCS.0b013e3182646043.
6
Botulinum toxin treatment for upper lid retraction of dysthyroidism.肉毒杆菌毒素治疗甲状腺功能障碍性上睑退缩
J Med Assoc Thai. 2003 Nov;86(11):1051-4.
7
Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series.曲安奈德结膜下注射治疗甲状腺眼病患者眼睑退缩:病例系列
Eye (Lond). 2008 Feb;22(2):311-5. doi: 10.1038/sj.eye.6702933. Epub 2007 Oct 5.
8
Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction--a pilot study.甲状腺相关性眼病:A型肉毒杆菌毒素治疗上睑退缩——一项初步研究
Acta Ophthalmol Scand. 2001 Dec;79(6):585-8. doi: 10.1034/j.1600-0420.2001.790608.x.
9
[Morphometric analysis of the palpebral fissure in patients with thyroid-related disfunction before and after application of botulinum toxin].[肉毒杆菌毒素应用前后甲状腺相关功能障碍患者睑裂的形态学分析]
Arq Bras Endocrinol Metabol. 2006 Oct;50(5):920-5. doi: 10.1590/s0004-27302006000500014.
10
Botulinum toxin type a for dysthyroid upper eyelid retraction.A型肉毒杆菌毒素治疗甲状腺功能异常性上睑退缩。
Ophthalmic Plast Reconstr Surg. 2004 May;20(3):181-5. doi: 10.1097/00002341-200405000-00001.

引用本文的文献

1
A critical appraisal of "efficacy and safety of botulinum toxin as a non-surgical option for upper eyelid retraction in active thyroid-associated ophthalmopathy".对“肉毒杆菌毒素作为活动性甲状腺相关性眼病上睑退缩非手术治疗选择的有效性和安全性”的批判性评价
Int Ophthalmol. 2025 Aug 25;45(1):355. doi: 10.1007/s10792-025-03742-9.
2
Efficacy and safety of botulinum toxin as a non-surgical option for upper eyelid retraction in active thyroid-associated ophthalmopathy: a prospective interventional study.肉毒杆菌毒素作为活动性甲状腺相关性眼病上睑退缩非手术治疗选择的疗效和安全性:一项前瞻性干预研究。
Int Ophthalmol. 2025 Jul 15;45(1):293. doi: 10.1007/s10792-025-03658-4.
3
Triamcinolone acetonide and botulinum toxin A for upper eyelid retraction in thyroid-associated ophthalmopathy.
曲安奈德和A型肉毒杆菌毒素用于甲状腺相关性眼病上睑退缩的治疗
Sci Rep. 2025 Feb 11;15(1):5103. doi: 10.1038/s41598-025-89063-4.
4
Nonsurgical management of upper eyelid retraction in thyroid eye disease.甲状腺眼病上睑退缩的非手术治疗
Taiwan J Ophthalmol. 2023 May 23;14(4):548-553. doi: 10.4103/tjo.TJO-D-23-00043. eCollection 2024 Oct-Dec.
5
Management of Graves' upper eyelid retraction (GUER): A review.格雷夫斯病上睑退缩的管理:综述
Indian J Ophthalmol. 2025 Feb 1;73(2):164-172. doi: 10.4103/IJO.IJO_748_24. Epub 2024 Dec 27.
6
Synergistic Therapy for Graves' Ophthalmopathy-Associated Eyelid Retraction: Steroid, 5-FU, and Botulinum Neurotoxin a Combination.格雷夫斯眼病相关眼睑退缩的协同治疗:类固醇、5-氟尿嘧啶和肉毒杆菌神经毒素A联合治疗
J Clin Med. 2024 May 20;13(10):3012. doi: 10.3390/jcm13103012.
7
Nonsurgical treatment for upper eyelid retraction in patients with inactive Graves' orbitopathy.非手术治疗活动性 Graves 眼病患者的上睑退缩。
Int Ophthalmol. 2023 Jul;43(7):2291-2299. doi: 10.1007/s10792-022-02625-7. Epub 2023 Jan 1.
8
Management of eyelid retraction related to thyroid eye disease.甲状腺眼病相关眼睑退缩的管理
Taiwan J Ophthalmol. 2022 Feb 14;12(1):12-21. doi: 10.4103/tjo.tjo_57_21. eCollection 2022 Jan-Mar.
9
Safety of Aesthetic Medicine Procedures in Patients with Autoimmune Thyroid Disease: A Literature Review.自身免疫性甲状腺疾病患者美容医学操作的安全性:文献综述
Medicina (Kaunas). 2021 Dec 24;58(1):30. doi: 10.3390/medicina58010030.
10
Comparison between hyaluronic acid filler and botulinum toxin type A in the treatment of thyroid upper eyelid retraction.透明质酸填充剂与A型肉毒毒素治疗甲状腺相关性上睑退缩的比较
Ther Adv Ophthalmol. 2020 Dec 28;12:2515841420979113. doi: 10.1177/2515841420979113. eCollection 2020 Jan-Dec.